日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy

MPS-Authors
/persons/resource/persons182320

Nave,  Klaus-Armin
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182406

Sereda,  Michael W.
Molecular and translational neurology, Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource
There are no locators available
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)

Chumakov_14.pdf
(出版社版), 2MB

付随資料 (公開)
There is no public supplementary material available
引用

Chumakov, I., Milet, A., Cholet, N., Primas, G., Boucard, A., Pereira, Y., Graudens, E., Mandel, J., Laffaire, J., Foucquier, J., Glibert, F., Bertrand, V., Nave, K.-A., Sereda, M. W., Vial, E., Guedj, M., Hajj, R., Nabirotchkin, S., & Cohen, D. (2014). Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet Journal of Rare Diseases, 9(1):. doi:10.1186/s13023-014-0201-x.


引用: https://hdl.handle.net/11858/00-001M-0000-002A-F732-7
要旨
要旨はありません